Vitiligo after Diphencyprone for Alopecia Areata

The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side...

Descripción completa

Detalles Bibliográficos
Autores principales: Pires, Mario Cezar, Martins, João Mauricio, Montealegre, F., Gatti, Flávia Romero
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879911/
https://www.ncbi.nlm.nih.gov/pubmed/20585597
http://dx.doi.org/10.1155/2010/171265
_version_ 1782181974173024256
author Pires, Mario Cezar
Martins, João Mauricio
Montealegre, F.
Gatti, Flávia Romero
author_facet Pires, Mario Cezar
Martins, João Mauricio
Montealegre, F.
Gatti, Flávia Romero
author_sort Pires, Mario Cezar
collection PubMed
description The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo. We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata.
format Text
id pubmed-2879911
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28799112010-06-28 Vitiligo after Diphencyprone for Alopecia Areata Pires, Mario Cezar Martins, João Mauricio Montealegre, F. Gatti, Flávia Romero Dermatol Res Pract Case Report The topical immunotherapy is used to treat alopecia areata and recalcitrant warts since the 1970s. Diphencyprone is a contact sensitizer used to treat dermatological conditions resulting from as altered immunological state, such as extensive alopecia areata, being partially effective and safe. Side effects include local eczema with blistering, regional lymphadenopathy and contact urticaria. Rare adverse effects include an erythema multiforme-like reaction, hyperpigmenttion, hypopigmentation, and vitiligo. We report a 30-year-old, Brazilian male who developed vitiligo lesions following DPCP therapy for alopecia areata. Hindawi Publishing Corporation 2010 2010-05-11 /pmc/articles/PMC2879911/ /pubmed/20585597 http://dx.doi.org/10.1155/2010/171265 Text en Copyright © 2010 Mario Cezar Pires et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Pires, Mario Cezar
Martins, João Mauricio
Montealegre, F.
Gatti, Flávia Romero
Vitiligo after Diphencyprone for Alopecia Areata
title Vitiligo after Diphencyprone for Alopecia Areata
title_full Vitiligo after Diphencyprone for Alopecia Areata
title_fullStr Vitiligo after Diphencyprone for Alopecia Areata
title_full_unstemmed Vitiligo after Diphencyprone for Alopecia Areata
title_short Vitiligo after Diphencyprone for Alopecia Areata
title_sort vitiligo after diphencyprone for alopecia areata
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2879911/
https://www.ncbi.nlm.nih.gov/pubmed/20585597
http://dx.doi.org/10.1155/2010/171265
work_keys_str_mv AT piresmariocezar vitiligoafterdiphencyproneforalopeciaareata
AT martinsjoaomauricio vitiligoafterdiphencyproneforalopeciaareata
AT montealegref vitiligoafterdiphencyproneforalopeciaareata
AT gattiflaviaromero vitiligoafterdiphencyproneforalopeciaareata

Ejemplares similares